Latest Tessera Technologies (TSRA) Headlines 16
Post# of 71
Posted On: 03/13/2014 3:01:41 PM
Latest Tessera Technologies (TSRA) Headlines
16.0% Return Seen to Date on SmarTrend Tessera Technologies Call (TSRA)
Comtex SmarTrend(R) - Thu Mar 13, 9:40AM CDT
SmarTrend identified an Uptrend for Tessera Technologies (NASDAQ:TSRA) on February 26th, 2014 at $19.98. In approximately 2 weeks, Tessera Technologies has returned 15.99% as of today's recent price of $23.17.
Expanding Portfolios with Innovative Products, Acquisitions, and Divestitures - Analyst Notes on Cree, Veeco, Synopsys, Tessera, and ATMI
PR Newswire - Thu Mar 13, 7:39AM CDT
Today, Analysts Review released its analysts' notes regarding Cree, Inc. (NASDAQ: CREE), Veeco Instruments Inc. (NASDAQ: VECO), Synopsys Inc. (NASDAQ: SNPS), Tessera Technologies Inc. (NASDAQ: TSRA), and ATMI Inc. (NASDAQ: ATMI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Tessera Technologies (TSRA): Moving Average Crossover Spotted - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 9:30AM CDT
Tessera Technologies (TSRA): Moving Average Crossover Spotted
Stock Worth Buying: Ultra Clean Holdings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 4:40PM CDT
Zacks Investment Research upgraded Ultra Clean Holdings Inc. to a Zacks Rank #1 (Strong Buy) on Mar 11, 2014. Going by the Zacks model, the companies holding a Zacks Rank #1 have strong chances of performing better than the broader market.
Updated Research Report on MKS Instruments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 12:40PM CST
On Feb 28, 2014, we issued an updated research report on MKS Instruments.
Research and Markets: Uremic (Renal) Pruritus Global Clinical Trials Review, H1, 2014
Business Wire - Fri Feb 28, 4:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/cdxv4c/uremic_renal) has announced the addition of the "Uremic (Renal) Pruritus Global Clinical Trials Review, H1, 2014" report to their offering.
Tessera Technologies Announces Settlement with PTI
Business Wire - Thu Feb 27, 11:29AM CST
Tessera Technologies, Inc. (NASDAQ:TSRA) ("Tessera" or the "Company") today announced that Tessera's subsidiary, Tessera, Inc., has entered into a settlement with Powertech Technology, Inc., Powertech Technology (Suzhou) Co. Ltd., and Macrotech Technology, Inc. (collectively "PTI") related to their pending cases in the United States District Court for the Northern District of California.
Research and Markets: Russia Orthopedic Prosthetics Market Outlook to 2020
Business Wire - Thu Feb 27, 6:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/wb93fz/russia_orthopedic) has announced the addition of the "Russia Orthopedic Prosthetics Market Outlook to 2020" report to their offering.
Tessera Technologies Announces Settlement with ASE
Business Wire - Mon Feb 24, 1:01PM CST
Tessera Technologies, Inc. (NASDAQ:TSRA) ("Tessera" or the "Company") today announced that Tessera's subsidiary, Tessera, Inc., has entered into an agreement with Advanced Semiconductor Engineering, Inc. and ASE (U.S.) Inc. (collectively, "ASE") to settle all claims at issue between ASE and Tessera, Inc. in the case styled Tessera, Inc: v. Advanced Micro Devices, Inc., et al. (Case No. 4:05-CV-04063 (United States District Court for the Northern District of California)).
Tessera announces dividend of USD0.10 per share for quarter
M2 - Wed Feb 12, 6:28AM CST
Holding company of operators in the Intellectual Property and DigitalOptics segments, Tessera Technologies Inc's (NASDAQ:TSRA) board of directors authorised a quarterly common stock cash dividend of USD0.10 per share, the company revealed on Tuesday.
Tessera Declares Quarterly Dividend
Business Wire - Tue Feb 11, 3:01PM CST
Tessera Technologies, Inc. (NASDAQ: TSRA) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per common share, to be paid on March 26, 2014, to all stockholders of record as of the close of business on March 5, 2014.
Infinity Group Portfolio Company 'WLCSP' Completes IPO and Begins Trading Publicly on the Shanghai Stock Exchange at a Market Trading Value of More than 1B USD
PR Newswire - Mon Feb 10, 8:00AM CST
Infinity Group announced today that portfolio company Wafer Level Chip Scale Package (WLCSP) has listed on the Shanghai Stock Exchange (Ticker: 603005.SH) and has raised US$118M with an IPO price of US$780M. The closing trading price today was US$27.59 per share, representing a more than US$1B market trading value. Founding investors of WLCSP include Infinity Group (Israel) and CVSC (China). Before today's IPO, the Israeli shareholders held 38% of WLCSP through various entities and partners. WLCSP is a wafer-level chip-scale packaging services company. It was established when, in 2005, Infinity bought semiconductor technology from Shellcase (today EIPAT) of Jerusalem and brought it to China. Infinity Group founder and managing partner Mr. Amir Gal-Or and Infinity Group managing director, finance, Mr. Ariel Poppel, are members of WLCSP's Board of Directors.
Tessera, Samsung Sign Patent Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 5:40PM CST
Recently, Tessera Technologies, Inc. declared that its subsidiaries Tessera, Inc. and Invensas Corp. have entered into new patent license agreements with Samsung.
Cricut Explore Makes World Debut Exclusively on HSN
Business Wire - Fri Feb 07, 7:15AM CST
--Bundle Offer Includes Exclusive Anna Griffin Design Cartridges and Three-Month Subscription to Cricut Design Space
Tessera's Q4 Earnings In Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 11:20AM CST
Tessera Technologies reported fourth-quarter 2013 earnings of 8 cents per share, in line with the Zacks Consensus Estimate.
Tessera Technologies Announces Fourth Quarter & Full Year 2013 Results
Business Wire - Wed Feb 05, 6:05AM CST
Tessera Technologies, Inc. (NASDAQ: TSRA) (the "Company" or "we") announced its results for the fourth quarter and full year ended Dec. 31, 2013. Total revenue from continuing operations for the fourth quarter of 2013 was $56.4 million. Generally accepted accounting principles (GAAP) net loss from continuing operations for the fourth quarter of 2013 was $46.2 million, or $0.86 per basic share, and included $45.3 million in impairment charges primarily related to the Company's previously announced decision to stop its mems|cam(TM)manufacturing business. Non-GAAP net income for the fourth quarter of 2013 was $7.7 million or $0.14 per diluted share.
Tessera's subsidiaries and Samsung sign new agreements for patent licensing
M2 - Wed Jan 29, 3:00AM CST
Tessera Technologies Inc (NASDAQ:TSRA), a holding company with subsidiaries that operate in the Intellectual Property and DigitalOptics segments, disclosed on Tuesday that its subsidiaries Tessera Inc and Invensas Corporation each signed new patent license agreements with Samsung Electronics Co Ltd (OTN:SSNLF), an electronic company within the Samsung Group.
Tessera Technologies to Announce Fourth Quarter 2013 Results
Business Wire - Tue Jan 28, 3:08PM CST
Tessera Technologies, Inc. (NASDAQ: TSRA) ("Tessera" or "the Company") will announce its fourth quarter and full year ended Dec. 31, 2013, earnings results before the market opens Wednesday, Feb. 5, 2014. The Company will host an earnings conference call at 5:00 A.M. Pacific (8:00 A.M. Eastern). On the conference call, management will also discuss the previously announced actions in the Company's DOC business and the new license agreements executed with Samsung.
Tessera and Samsung Enter into New Patent License Agreements
Business Wire - Tue Jan 28, 3:05PM CST
Tessera Technologies, Inc. (NASDAQ: TSRA) ("Tessera") and Samsung Electronics Co., Ltd. (OTN: SSNLF) ("Samsung") announced today that Tessera's subsidiaries Tessera, Inc. and Invensas Corporation each entered into new patent license agreements with Samsung.
16.0% Return Seen to Date on SmarTrend Tessera Technologies Call (TSRA)
Comtex SmarTrend(R) - Thu Mar 13, 9:40AM CDT
SmarTrend identified an Uptrend for Tessera Technologies (NASDAQ:TSRA) on February 26th, 2014 at $19.98. In approximately 2 weeks, Tessera Technologies has returned 15.99% as of today's recent price of $23.17.
Expanding Portfolios with Innovative Products, Acquisitions, and Divestitures - Analyst Notes on Cree, Veeco, Synopsys, Tessera, and ATMI
PR Newswire - Thu Mar 13, 7:39AM CDT
Today, Analysts Review released its analysts' notes regarding Cree, Inc. (NASDAQ: CREE), Veeco Instruments Inc. (NASDAQ: VECO), Synopsys Inc. (NASDAQ: SNPS), Tessera Technologies Inc. (NASDAQ: TSRA), and ATMI Inc. (NASDAQ: ATMI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Tessera Technologies (TSRA): Moving Average Crossover Spotted - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 9:30AM CDT
Tessera Technologies (TSRA): Moving Average Crossover Spotted
Stock Worth Buying: Ultra Clean Holdings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 4:40PM CDT
Zacks Investment Research upgraded Ultra Clean Holdings Inc. to a Zacks Rank #1 (Strong Buy) on Mar 11, 2014. Going by the Zacks model, the companies holding a Zacks Rank #1 have strong chances of performing better than the broader market.
Updated Research Report on MKS Instruments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 12:40PM CST
On Feb 28, 2014, we issued an updated research report on MKS Instruments.
Research and Markets: Uremic (Renal) Pruritus Global Clinical Trials Review, H1, 2014
Business Wire - Fri Feb 28, 4:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/cdxv4c/uremic_renal) has announced the addition of the "Uremic (Renal) Pruritus Global Clinical Trials Review, H1, 2014" report to their offering.
Tessera Technologies Announces Settlement with PTI
Business Wire - Thu Feb 27, 11:29AM CST
Tessera Technologies, Inc. (NASDAQ:TSRA) ("Tessera" or the "Company") today announced that Tessera's subsidiary, Tessera, Inc., has entered into a settlement with Powertech Technology, Inc., Powertech Technology (Suzhou) Co. Ltd., and Macrotech Technology, Inc. (collectively "PTI") related to their pending cases in the United States District Court for the Northern District of California.
Research and Markets: Russia Orthopedic Prosthetics Market Outlook to 2020
Business Wire - Thu Feb 27, 6:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/wb93fz/russia_orthopedic) has announced the addition of the "Russia Orthopedic Prosthetics Market Outlook to 2020" report to their offering.
Tessera Technologies Announces Settlement with ASE
Business Wire - Mon Feb 24, 1:01PM CST
Tessera Technologies, Inc. (NASDAQ:TSRA) ("Tessera" or the "Company") today announced that Tessera's subsidiary, Tessera, Inc., has entered into an agreement with Advanced Semiconductor Engineering, Inc. and ASE (U.S.) Inc. (collectively, "ASE") to settle all claims at issue between ASE and Tessera, Inc. in the case styled Tessera, Inc: v. Advanced Micro Devices, Inc., et al. (Case No. 4:05-CV-04063 (United States District Court for the Northern District of California)).
Tessera announces dividend of USD0.10 per share for quarter
M2 - Wed Feb 12, 6:28AM CST
Holding company of operators in the Intellectual Property and DigitalOptics segments, Tessera Technologies Inc's (NASDAQ:TSRA) board of directors authorised a quarterly common stock cash dividend of USD0.10 per share, the company revealed on Tuesday.
Tessera Declares Quarterly Dividend
Business Wire - Tue Feb 11, 3:01PM CST
Tessera Technologies, Inc. (NASDAQ: TSRA) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per common share, to be paid on March 26, 2014, to all stockholders of record as of the close of business on March 5, 2014.
Infinity Group Portfolio Company 'WLCSP' Completes IPO and Begins Trading Publicly on the Shanghai Stock Exchange at a Market Trading Value of More than 1B USD
PR Newswire - Mon Feb 10, 8:00AM CST
Infinity Group announced today that portfolio company Wafer Level Chip Scale Package (WLCSP) has listed on the Shanghai Stock Exchange (Ticker: 603005.SH) and has raised US$118M with an IPO price of US$780M. The closing trading price today was US$27.59 per share, representing a more than US$1B market trading value. Founding investors of WLCSP include Infinity Group (Israel) and CVSC (China). Before today's IPO, the Israeli shareholders held 38% of WLCSP through various entities and partners. WLCSP is a wafer-level chip-scale packaging services company. It was established when, in 2005, Infinity bought semiconductor technology from Shellcase (today EIPAT) of Jerusalem and brought it to China. Infinity Group founder and managing partner Mr. Amir Gal-Or and Infinity Group managing director, finance, Mr. Ariel Poppel, are members of WLCSP's Board of Directors.
Tessera, Samsung Sign Patent Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 5:40PM CST
Recently, Tessera Technologies, Inc. declared that its subsidiaries Tessera, Inc. and Invensas Corp. have entered into new patent license agreements with Samsung.
Cricut Explore Makes World Debut Exclusively on HSN
Business Wire - Fri Feb 07, 7:15AM CST
--Bundle Offer Includes Exclusive Anna Griffin Design Cartridges and Three-Month Subscription to Cricut Design Space
Tessera's Q4 Earnings In Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 11:20AM CST
Tessera Technologies reported fourth-quarter 2013 earnings of 8 cents per share, in line with the Zacks Consensus Estimate.
Tessera Technologies Announces Fourth Quarter & Full Year 2013 Results
Business Wire - Wed Feb 05, 6:05AM CST
Tessera Technologies, Inc. (NASDAQ: TSRA) (the "Company" or "we") announced its results for the fourth quarter and full year ended Dec. 31, 2013. Total revenue from continuing operations for the fourth quarter of 2013 was $56.4 million. Generally accepted accounting principles (GAAP) net loss from continuing operations for the fourth quarter of 2013 was $46.2 million, or $0.86 per basic share, and included $45.3 million in impairment charges primarily related to the Company's previously announced decision to stop its mems|cam(TM)manufacturing business. Non-GAAP net income for the fourth quarter of 2013 was $7.7 million or $0.14 per diluted share.
Tessera's subsidiaries and Samsung sign new agreements for patent licensing
M2 - Wed Jan 29, 3:00AM CST
Tessera Technologies Inc (NASDAQ:TSRA), a holding company with subsidiaries that operate in the Intellectual Property and DigitalOptics segments, disclosed on Tuesday that its subsidiaries Tessera Inc and Invensas Corporation each signed new patent license agreements with Samsung Electronics Co Ltd (OTN:SSNLF), an electronic company within the Samsung Group.
Tessera Technologies to Announce Fourth Quarter 2013 Results
Business Wire - Tue Jan 28, 3:08PM CST
Tessera Technologies, Inc. (NASDAQ: TSRA) ("Tessera" or "the Company") will announce its fourth quarter and full year ended Dec. 31, 2013, earnings results before the market opens Wednesday, Feb. 5, 2014. The Company will host an earnings conference call at 5:00 A.M. Pacific (8:00 A.M. Eastern). On the conference call, management will also discuss the previously announced actions in the Company's DOC business and the new license agreements executed with Samsung.
Tessera and Samsung Enter into New Patent License Agreements
Business Wire - Tue Jan 28, 3:05PM CST
Tessera Technologies, Inc. (NASDAQ: TSRA) ("Tessera") and Samsung Electronics Co., Ltd. (OTN: SSNLF) ("Samsung") announced today that Tessera's subsidiaries Tessera, Inc. and Invensas Corporation each entered into new patent license agreements with Samsung.
(0)
(0)Adeia Inc. (ADEA) Stock Research Links
Scroll down for more posts ▼